Tags : Welldoc

Astellas Signs a License Agreement with Welldoc to Develop and

Shots: Welldoc to receive $15M upfront, development & commercialization milestones and royalties on sales. Astellas and Welldoc will jointly develop and commercialize BlueStar for patients with diabetes in Asian countries including Japan The companies will co-develop & co-commercialize digital therapies globally for multiple therapeutic areas. The collaboration allows Welldoc to widen its platform in other […]Read More